Increased fetal size in gestational diabetes after week 20 of pregnancy
1. Study findings suggest gestational diabetes is associated with larger fetal size starting at week 20, and that efforts to mitigate associated fetal growth...
Treatment at lower glucose threshold noninferior to traditional threshold in newborns with asymptomatic hypoglycemia
1. In this randomized noninferiority trial involving newborns with asymptomatic moderate hypoglycemia, initiation of treatment at a lower blood glucose threshold resulted in no...
Antenatal vitamin D supplementation does not prevent development of asthma
1. This 6-year follow up of the Vitamin D Antenatal Asthma Reduction Trial found no significant difference in the incidence of asthma or recurrent...
Annual mammography past 75 years of age not associated with reductions in mortality
1. In this observational study involving women aged 70 to 84 years with a life expectancy of at least 10 years, continuing screening past...
Folic acid and zinc supplementation in men not associated with increased fertility
1. In couples obtaining infertility treatment, folic acid and zinc supplementation in men did not lead to a significant improvement in semen quality or...
Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy
1. Antiepileptic drug exposure in infants of breastfeeding mothers being treated for epilepsy is low.
Evidence Rating Level: 2 (Good)
While breastfeeding for the first 6 months...
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant...
1. Digital cognitive behavioral therapy for insomnia (CBT-I) resulted in significant decreases in severity of insomnia, depressive, and anxiety symptoms compared to standard treatment...
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
1. In this pair of identical phase 3 trials involving premenopausal women with uterine fibroids, both elagolix with and without add-back therapy was more...
Cost effectiveness of extending human papillomavirus vaccine administration until age 45
1. The FDA approved the expansion of the human papillomavirus (HPV) vaccination from ages 9 to 26 in women and 21 in men to...
High dose erythropoietin may not be efficacious for neuroprotection in extremely preterm infants
1. In this randomized controlled trial involving extremely preterm infants, high dose erythropoietin did not reduce the risk of death or severe neurodevelopmental impairment...
